Skip to content

Konstantin Gerber

3 papers in the library · 72 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

Whose HOPE? Power, knowledge, and the decolonization of psychedelic ethics

Journal of Psychedelic Studies September 10, 2026 Fernanda Kaingáng, Daiara Tukano, Adana Omágua-Kambeba et al.

Abstract The global expansion of psychedelic research, clinical translation, and policy reform has intensified debates concerning safety, equity, cultural appropriation, and Indigenous rights. A prominent contribution to these discussions is the Hopkins–Oxford Psychedelic Ethics (HOPE) Consensus Statement (Jacobs et al., 2024), which proposes a foundational ethical framework for a field...

Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation

Transcultural Psychiatry January 6, 2022 Eduardo Ekman Schenberg, Konstantin Gerber 18 citations

After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were...

Ethical Concerns about Psilocybin Intellectual Property

ACS Pharmacology & Translational Science 2021 Konstantin Gerber, Inti García Flores, Angela Christina Ruiz et al. 54 citations

Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous...